SNGX

0.22018.29%
RJ

Robert J. Rubin

Independent Director

Dr. Robert J. Rubin, M.D., FACP, is the Co-Founder, since July 2022 as Interim Chief Medical Officer & Director at Cerium Pharmaceuticals, Inc. He serves as a Clinical Professor of Medicine at Georgetown University's School of Medicine since 1995 until 2012 when he was appointed a Distinguished Professor of Medicine. Dr. Rubin serves as a Consultant to several large international healthcare companies. He served as President at The Lewin Group, Inc. and its predecessor organizations from 1987 to 2001. Dr. Rubin served as Medical Director at ValueRx from 1994 to 1996. He served as President of Lewin-VHI from 1992 to 1996 and Lewin-ICF from 1987 to 1992. Dr. Rubin served as a Principal of ICF, Inc. from 1984 to 1987. He served as Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services and as an Assistant Surgeon General in the United States Public Health Service from 1981 to 1984. Dr. Rubin served as Independent Director at BioTelemetry, Inc. since July 2007 until February 09, 2021 and has been an Independent Director of Soligenix, Inc. since October 8, 2009. He serves as a Member of Advisory Board at Consumer Health Advisers, Inc. He serves as Member of the Scientific Advisory Board at TcLand Expression SA. Dr. Rubin served as a Director of Questcor Pharmaceuticals Inc. from September 26, 2007 to May 2008. He serves as Chair of the Research Council of the Institute for Health Technology Studies and Chair-Elect of the Association for Weight Management and Obesity Prevention. Dr. Rubin was Chairman of inter and intra departmental task forces responsible for the design, passage and implementation of Medicare's Prospective Payment System. He is a Board Certified Nephrologist and Internist. Dr. Rubin is a practicing Nephrologist. He holds an A.B in Political Science from Williams College and an M.D. from Cornell University Medical College. Dr. Rubin served as a Member of Scientific Advisory Board at Halt Medical Inc. since July 2010.

Positions